Xaga Surgical

Xaga Surgical is a Swedish based Health Care startup that aims to revolutionize medical needle technology to minimize the risk of infections. Their patented and patent pending medical needles are designed to address the critical need for infection prevention in medical procedures, particularly in the face of increasing antibiotic resistance. The startup's flagship product is a biopsy needle specifically developed to reduce bacterial transmission, thereby mitigating the risk of sepsis during prostate cancer diagnosis. This innovation has demonstrated a significant reduction of 96% in bacterial transmission, offering a compelling solution to a pressing problem in the medical field. With a founding date in 2016, Xaga Surgical has recently received a kr4.00M Venture Round investment on 06 October 2021, with the investment coming from SmiLe Venture Hub. This financial backing reflects the confidence of investors in Xaga Surgical's innovative approach to addressing a critical issue in healthcare, signaling potential for significant impact and growth within the industry.